This session introduces the European medical cannabis market, including key patient trends and regulatory developments that have propelled the conversation around cannabis as a therapeutic alternative forward. Particular focus is devoted to the patient interest in medical cannabis and practical problems faced by pharmacists who are interested to learn more but cautious as to the source of information. Nick Pateras also addresses consequential insights from Canada’s experience and how medical professionals in Europe can apply those learnings to their own approach towards medical cannabis.
An dieser Stelle finden Sie einen externen Inhalt von YouTube, welcher unseren Artikel ergänzt. Zur Anzeige dieses Inhalts müssen Sie den Datenschutzeinstellungen für externe Medien von YouTube zustimmen.
Cookie Einstellungen öffnen